INDIANAPOLIS, Dec. 08, 2017 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and... Read more »
Wall Street ticked higher on Friday after a stronger-than-predictable jobs data for November showed that the world’s leading economy has gained strength, ahead of a near certain interest rate hike next week.... Read more »
Top analyst Vijay Rakesh at Mizuho just held investor meetings with Micron Technology, Inc. (NASDAQ:MU) CFO Ernie Maddock at his 2017 annual Mizuho Investor Conference (MIC). The verdict? Pay no attention to... Read more »
Cara Therapeutics, Inc. (NASDAQ:CARA) shares are up more than 37.03% this year and recently increased 0.71% or $0.09 to settle at $12.82. Hemispherx Biopharma, Inc. (NYSE:HEB), on the other hand, is down... Read more »
In taking a look at some key indicators for The Goldman Sachs Group, Inc. (NYSE:GS), we note that the current Book to Market value for the firm is at 0.799840. The Book... Read more »
With all other things going on, Fitbit, Inc. (NYSE:FIT) has been on a run — rising 7.79 percent in just three months. It looks like traders are happy with the stock. On... Read more »
Needle moving action has been spotted in Akari Therapeutics (AKTX) as shares are moving today on volatility -0.99% or -0.05 from the open. The NASDAQ listed company saw a recent bid of 4.99 and 367091 shares have traded hands... Read more »
December 08 was a positive day for Valeant Pharmaceuticals International Inc. (VRX:CA) as its stock finished the day having gained 11.82% to hit a price of $25.36 a share. The company reached... Read more »